Navigation Links
Spherix to Present at the LHA Life Sciences & Medical Technologies Virtual Conference on February 16
Date:2/10/2012

BETHESDA, Md., Feb. 10, 2012 /PRNewswire/ -- Spherix Incorporated (NASDAQ: SPEX) -- an innovator in biotechnology for therapy in diabetes, metabolic syndrome and atherosclerosis, and provider of technical and regulatory consulting services to food, supplement, biotechnology and pharmaceutical companies -- today announced that Dr. Claire Kruger, Chief Executive Officer, will present to investors as part of the LHA, Inc. Life Sciences & Medical Technologies Virtual Conference on Thursday, February 16, 2012, at 12:30 p.m. Eastern time.

The webcast of the Spherix presentation will be accessible live and for 30 days at www.spherix.com or the PrecisionIR event site http://www.investorcalendar.com/IC/CEPage.asp?ID=167333.

This virtual conference event includes 30-minute presentations with accompanying slides from eight industry leaders, and begins at 9:00 a.m. Eastern time.

About Spherix
Spherix Incorporated was launched in 1967 as a scientific research company under the name Biospherics Research.  The Company now leverages its scientific and technical expertise and experience through its two subsidiaries – Biospherics Incorporated and Spherix Consulting, Inc.  Biospherics is dedicated to developing and licensing/marketing proprietary therapeutic products for treatment of diabetes, metabolic syndrome and atherosclerosis.  Biospherics is actively seeking a pharmaceutical partner to continue the development of its Phase 3 compound for the treatment of diabetes, D-tagatose, while exploring new drugs and combinations for treatment of high triglycerides, a risk factor for atherosclerosis, myocardial infarction, and stroke.  Spherix's Consulting subsidiary provides scientific and strategic support for suppliers, manufacturers, distributors and retailers of conventional foods, biotechnology-derived f
'/>"/>

SOURCE Spherix Incorporated
Copyright©2010 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3

Related biology technology :

1. Spherix Announces Registered Direct Offering of $1.15 Million
2. Spherix Announces Successful Completion of Important Toxicology Study of SPX-106
3. Spherix Announces Third Quarter Financial Results
4. Spherix Announces Closing of Private Placement of $1.25 Million, Discusses Use of Proceeds
5. Spherix to Raise $1.25 Million in Private Placement
6. Spherix Announces Results from New Preclinical Studies Showing SPX-106T Produces Significant Reductions in Cholesterol, Fat Deposition and Body Weight
7. Spherix Announces Annual Shareholders Meeting Date
8. Spherix to Present at the 5th Lippert/Heilshorn Life Sciences & Medical Technologies Virtual Conference on June 16
9. Spherix Regains Compliance With NASDAQ Listing Rule
10. Spherix Announces First Quarter Financial Results
11. Spherix Announces Reverse Stock Split Effective May 6, 2011
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2012)... a timely and reliable way to obtain enough raw ... the tissue they need to build. In a new ... viscosity, and other mechanical properties of adult stem cells ... whether they will turn into bone, cartilage, or fat. ... of extracting the needed cells from a larger and ...
(Date:5/21/2012)... Elsevier,s Computers & Graphics announces the upcoming ... which will incorporate the Collage Authoring Environment, a workflow ... of the 2011 Executable Paper Grand Challenge. The call ... Eurographics 2012 on May 13, during the 3DOR Workshop. ... to embed chunks of executable code and data into ...
(Date:5/21/2012)... International scientific and government experts held a ... use of Oxitec,s genetically modified Aedes aegypti ... Panama. The independent forum was co-organised by ... Institute for Health Studies and the University of Panama. ... institutes as well as the Pan American Health Organisation, ...
(Date:5/18/2012)...  Intellect Neurosciences, Inc. (OTCPK: ILNS) announces that ... CEO, will be presenting at the Seventh Annual ... (Logo:  http://photos.prnewswire.com/prnh/20111214/NY22484LOGO ) The title ... Offer Attractive Targets for Active and Passive Immunotherapy." ... at the Intercontinental Hotel in Boston from 10:15-11:30 ...
Breaking Biology Technology:Physical properties predict stem cell outcome 2Physical properties predict stem cell outcome 3Expert Meeting Discusses Testing of Oxitec Transgenic Mosquitoes in Panama 2Expert Meeting Discusses Testing of Oxitec Transgenic Mosquitoes in Panama 3Intellect Neurosciences, Inc. to Present at Neurotech Investing and Partnering Conference 2Intellect Neurosciences, Inc. to Present at Neurotech Investing and Partnering Conference 3
... On January 7,2008, Signalife received a deficiency letter ... it advised that Signalife would need to,comply with ... listing under AMEX Rules 1003(a)(iii). This notification was,triggered ... less than,$50 million, which previously exempted Signalife from ...
... New Agent for CLL Patients Approved by the FDA ... Cephalon, Inc. (Nasdaq:,CEPH) today announced that the U.S. Food ... Injection for the,treatment of patients with chronic lymphocytic leukemia ... American Cancer Society,estimates that more than 15,000 new cases ...
... study setup and launch..., WAYLAND, Mass., March ... clinical trials software, announces the,launch of its Trident ... unique parameter driven + custom pluggable design,leaps ahead ... a new era,of needed scalability, productivity, and ease-of-use ...
Other Biology Technology:AMEX Notifies Signalife That It Has Accepted Signalife's Plan of Compliance 2Cephalon Receives FDA Approval for TREANDA, a Novel Chemotherapy for Chronic Lymphocytic Leukemia 2Cephalon Receives FDA Approval for TREANDA, a Novel Chemotherapy for Chronic Lymphocytic Leukemia 3Cephalon Receives FDA Approval for TREANDA, a Novel Chemotherapy for Chronic Lymphocytic Leukemia 4Cephalon Receives FDA Approval for TREANDA, a Novel Chemotherapy for Chronic Lymphocytic Leukemia 5Tourtellotte's New Trident IWR(TM) Eliminates 12-Week Study Setup Lead Time for Clinical Trials 2Tourtellotte's New Trident IWR(TM) Eliminates 12-Week Study Setup Lead Time for Clinical Trials 3
(Date:5/21/2012)... University of Singapore,s (NUS) Department of Biological Sciences and ... a compound that is undergoing preclinical trials as a ... and stop them from growing into a tumour. This ... the first time a research group has provided evidence ... , Building on the new findings, the NUS team ...
(Date:5/21/2012)... teams of Australian and US scientists has found there ... Antarctic Bottom Water found off the coast of Antarctica.,Comparing ... Southern Ocean marine science voyage to historical data dating ... much as a 60 per cent reduction in the ... that drives global ocean currents. , In an intensive ...
(Date:5/20/2012)... (HDAC) inhibitor panobinostat is able to target and ... study published in BioMed Central,s open access journal ... University Health Sciences Center have shown that panobinostat ... reduce tumor growth in mice. , Approximately 15% ... be triple negative. These aggressive tumours are missing ...
Breaking Biology News(10 mins):Novel discovery by NUS scientists paves the way for more effective treatment of cancers 2Latest Southern Ocean research shows continuing deep ocean change 2Latest Southern Ocean research shows continuing deep ocean change 3Blocking DNA: HDAC inhibitor targets triple negative breast cancer 2San Diego State Offers Project Management Programs Beginning in January 61681 1San Diego State Offers Project Management Programs Beginning in January 61681 2Hobbits are a new human species according to the statistical analysis of fossils 10800 1Hobbits are a new human species according to the statistical analysis of fossils 10800 2Marrone Bio Innovations Named an IC20 Company 14914 1Marrone Bio Innovations Named an IC20 Company 14914 2
... Institute on Drug Abuse (NIDA), part of the National ... genes that might increase a person’s ability to abstain ... George Uhl at NIDA’s Intramural Research Program and a ... for Nicotine and Smoking Cessation Research at Duke University ...
... MIT have created an ocean model so realistic that the ... in population patterns that precisely mimic their real-world counterparts. , ... the vast diversity of the invisible forests living in our ... half the oxygen we breathe on Earth. And it does ...
... of millipede was recently discovered by a Northern Arizona ... researcher. , J. Judson Wynne, with the Department ... with the U.S. Geological Survey's Southwest Biological Center, and ... of Land Management (BLM), collected specimens leading to the ...
Other Biology News:NIDA study identifies genes that might help some people abstain from smoking 2MIT's ocean model captures diversity of underwater forests 2MIT's ocean model captures diversity of underwater forests 3Discovery of new cave millipedes casts light on Arizona cave ecology 2Discovery of new cave millipedes casts light on Arizona cave ecology 3